Review: taking Ritalin and Risperdal consta together


Summary

Drug interactions are reported among people who take Ritalin and Risperdal consta together. This review analyzes the effectiveness and drug interactions between Ritalin and Risperdal consta. It is created by eHealthMe based on reports of 1,397 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Ritalin and Risperdal consta >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Ritalin

Ritalin has active ingredients of methylphenidate hydrochloride. It is often used in attention deficit hyperactivity disorder. (latest outcomes from Ritalin 12,382 users)

Risperdal Consta

Risperdal consta has active ingredients of risperidone. It is often used in schizophrenia. (latest outcomes from Risperdal consta 5,703 users)

On Aug, 26, 2016

1,397 people who take Ritalin, Risperdal Consta are studied.


Number of reports submitted per year:

Ritalin and Risperdal consta drug interactions.

Drug effectiveness over time:

Ritalin:
  • < 1 month: 20.0% - (2 of 10 people)
  • 1 - 6 months: 10.0% - (1 of 10 people)
  • 6 - 12 months: 100.0% - (2 of 2 people)
  • 1 - 2 years: 52.0% - (10 of 19 people)
  • 2 - 5 years: 29.0% - (5 of 17 people)
  • 5 - 10 years: 50.0% - (1 of 2 people)
  • 10+ years: 50.0% - (1 of 2 people)
  • not specified: 0.0% - (0 of 1 people)
Risperdal Consta:
  • < 1 month: 18.0% - (2 of 11 people)
  • 1 - 6 months: 16.0% - (2 of 12 people)
  • 6 - 12 months: 28.0% - (2 of 7 people)
  • 1 - 2 years: 23.0% - (3 of 13 people)
  • 2 - 5 years: 38.0% - (5 of 13 people)
  • 5 - 10 years: 60.0% - (3 of 5 people)
  • 10+ years: 0.0% - (0 of 1 people)
  • not specified: 50.0% - (1 of 2 people)

Drug effectiveness by gender:

Ritalin:
  • female: 21.0% - (5 of 23 people)
  • male: 42.0% - (17 of 40 people)
Risperdal Consta:
  • female: 33.0% - (7 of 21 people)
  • male: 25.0% - (11 of 43 people)

Drug effectiveness by age:

Ritalin:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 29.0% - (5 of 17 people)
  • 10-19: 39.0% - (9 of 23 people)
  • 20-29: 25.0% - (3 of 12 people)
  • 30-39: 33.0% - (2 of 6 people)
  • 40-49: 100.0% - (2 of 2 people)
  • 50-59: 0.0% - (0 of 2 people)
  • 60+: 100.0% - (1 of 1 people)
Risperdal Consta:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 10.0% - (2 of 19 people)
  • 10-19: 28.0% - (6 of 21 people)
  • 20-29: 30.0% - (4 of 13 people)
  • 30-39: 66.0% - (4 of 6 people)
  • 40-49: 33.0% - (1 of 3 people)
  • 50-59: 50.0% - (1 of 2 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • agitation
  • aggression
  • dyskinesia
  • convulsion
  • rhabdomyolysis
  • tachycardia
  • cytolytic hepatitis
  • dehydration
  • hyperthermia
  • renal failure acute
1 - 6 months:
  • abnormal behaviour
  • insomnia
  • type 1 diabetes mellitus
  • weight increased
  • diabetes mellitus
  • hallucination, visual
  • chest discomfort
  • essential hypertension
  • impulse-control disorder
  • nasal congestion
6 - 12 months:
  • tic
  • tachycardia
  • abnormal behaviour
  • fatigue
  • hyperhidrosis
  • aggression
  • cough
  • night sweats
  • blood triglycerides increased
  • palpitations
1 - 2 years:
  • diabetes mellitus
  • decreased appetite
  • tic
  • type 2 diabetes mellitus
  • weight decreased
  • blood pressure increased
  • obesity
  • sensation of foreign body
  • tachycardia
  • tardive dyskinesia
2 - 5 years:
  • aggression
  • agitation
  • dyskinesia
  • blood triglycerides increased
  • dehydration
  • obesity
  • renal failure acute
  • cytolytic hepatitis
  • hyperthermia
  • rhabdomyolysis
5 - 10 years:
  • weight increased
  • gynaecomastia
  • type 2 diabetes mellitus
  • abnormal behaviour
  • blood triglycerides increased
  • dyskinesia
  • emotional disorder
  • emotional distress
  • hyperprolactinaemia
  • lethargy
10+ years:
  • abnormal behaviour
  • affective disorder
  • coordination abnormal
  • disturbance in attention
  • dry mouth
  • dyskinesia
  • dystonia
  • muscular weakness
  • musculoskeletal stiffness
  • tardive dyskinesia
not specified:
  • aggression
  • weight increased
  • drug ineffective
  • abnormal behaviour
  • insomnia
  • depression
  • agitation
  • diabetes mellitus
  • suicidal ideation
  • dizziness

Most common drug interactions by gender *:

female:
  • dizziness
  • insomnia
  • diabetes mellitus
  • depression
  • drug ineffective
  • weight increased
  • pain
  • suicidal ideation
  • type 2 diabetes mellitus
  • anxiety
male:
  • aggression
  • abnormal behaviour
  • weight increased
  • drug ineffective
  • agitation
  • insomnia
  • dyskinesia
  • tachycardia
  • depression
  • tic

Most common drug interactions by age *:

0-1:
  • aggression
  • convulsion
  • agitation
  • foaming at mouth
  • pancreatitis acute
  • tardive dyskinesia
2-9:
  • aggression
  • dyskinesia
  • tachycardia
  • agitation
  • abnormal behaviour
  • hyperthermia
  • drug administration error
  • tic
  • drug ineffective
  • dehydration
10-19:
  • weight increased
  • abnormal behaviour
  • aggression
  • drug ineffective
  • insomnia
  • diabetes mellitus
  • agitation
  • suicide attempt
  • weight decreased
  • attention deficit/hyperactivity disorder
20-29:
  • insomnia
  • dizziness
  • dyspnoea
  • paranoia
  • asthenia
  • completed suicide
  • deep vein thrombosis
  • hallucination, auditory
  • headache
  • hypokalaemia
30-39:
  • diabetes mellitus
  • depression
  • insomnia
  • suicidal ideation
  • priapism
  • ventricular tachycardia
  • palpitations
  • aggression
  • anxiety
  • liver function test abnormal
40-49:
  • type 2 diabetes mellitus
  • depression
  • insomnia
  • blood cholesterol increased
  • obesity
  • road traffic accident
  • somnolence
  • speech disorder
  • chest pain
  • dyskinesia
50-59:
  • dizziness
  • paraesthesia
  • nausea
  • type 2 diabetes mellitus
  • depression
  • suicide attempt
  • weight increased
  • extrapyramidal disorder
  • muscle twitching
  • parkinsonism
60+:
  • dyspnoea
  • pain
  • urinary tract infection
  • anxiety
  • depression
  • insomnia
  • pain in extremity
  • atrial fibrillation
  • back pain
  • bone pain

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Ritalin and Risperdal consta?

Can you answer these questions?

More questions for: Ritalin, Risperdal consta

You may be interested in these reviews

More reviews for: Ritalin, Risperdal consta

On eHealthMe, Ritalin (methylphenidate hydrochloride) is often used to treat attention deficit hyperactivity disorder. Risperdal consta (risperidone) is often used to treat schizophrenia. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.